A prospective study measuring the development of antibodies against platelet factor 4–heparin in healthy males after exposure to heparins

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|10|7|1446-1449

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.10, Iss.7, 2012-07, pp. : 1446-1449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preexisting Antibodies to Platelet Factor 4-Heparin Complexes in Patients with Acute Coronary Syndrome Who Have No History of Heparin Exposure

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 1, 2005-11 ,pp. : 18-22

Karger

Access to resources Recommend Favorite

Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 1538-7933, Iss. 10, 2015-10 ,pp. : 1900-1907

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 8, 2015-08 ,pp. : 1416-1427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Complexes of platelet factor 4 and heparin activate Toll‐like receptor 4

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 4, 2015-04 ,pp. : 665-670

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of Antibodies Against Cytomegalovirus, Varicella-zoster Virus and Herpes Simplex Virus in Finland During the First Eight Years Of Life: A Prospective Study

By Aarnisalo Johanna   Ilonen Jorma   Vainionpää Raija   Volanen Iina   Kaitosaari Tuuli   Simell Olli  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 10, 2003-10 ,pp. : 750-753

Informa Healthcare

Access to resources Recommend Favorite